Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS) Bundle
Ningbo Sanxing Medical Electric Co., Ltd. traces its roots to a 1986 watch-parts workshop and has since transformed into a global smart-power and medical-device player-listed on the Shanghai Stock Exchange in 2011 under 601567.SS-with a vertically integrated model spanning R&D institutes in Hangzhou and Ningbo, manufacturing bases that by 2015 expanded to Brazil and Indonesia and by 2023 to Germany and Mexico, plus new sales companies in Malaysia, Thailand and the U.S. and a 2025 production base in Kenya; today the firm has approximately 1.41 billion shares outstanding (≈616 million free float) with insiders holding 61.78%, institutional ownership at 16.88%, a debt-to-equity of 0.6 and debt/EBITDA of 1.8, invests roughly 10-15% of revenue into R&D (≈¥180 million / $27M in 2022) to develop smart meters, EV chargers, transformers and high-demand medical devices that drove about ¥1.8 billion in medical-segment revenue in 2022 and underpin a domestic medical-device market share near 25% as analysts project CN¥17.2 billion revenue in 2025 and UBS sets a RMB30.00 price target while the company pushes aggressive expansion in Southeast Asia and Africa.
Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS): Intro
History and key milestones- 1986 - Founded as Longguan Watch & Clock Parts Factory in Ningbo, Zhejiang Province.
- 1989 - Transitioned into the meter industry and established the Sanxing brand.
- 2011 - Listed on the Shanghai Stock Exchange (ticker 601567), entering the public capital market.
- 2012 - Launched dedicated R&D institutes in Hangzhou and Ningbo focused on smart grid and smart home appliance technologies.
- 2015 - Expanded manufacturing footprint internationally with plants in Brazil and Indonesia; acquired AUX International Holdings Limited (HKEX-listed) and rebranded it AUX International.
- 2023 - Accelerated global brand promotion: established sales companies in Malaysia, Thailand, and the United States; added manufacturing bases in Germany and Mexico.
- July 2025 - Opened a new production base in Kenya, expanding operations into Africa.
- Publicly listed parent: Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS) - shares traded on the Shanghai Stock Exchange.
- Major arms and holdings include domestic manufacturing, R&D institutes (Hangzhou, Ningbo), and overseas subsidiaries/production bases (Brazil, Indonesia, Germany, Mexico, Kenya).
- Strategic acquisition: AUX International (acquired 2015) - positioned to strengthen HVAC and home-appliance channels and international distribution.
- Governance: Board, executive management and institutional shareholders typical of a Shanghai-listed industrial group (foundation/management shareholdings plus institutional investors and public float).
- Mission: Develop reliable, energy-efficient electrical and medical-related equipment while elevating smart-home and smart-grid integration capabilities.
- Vision: Globalize independent brands and deliver cross-border manufacturing and after-sales services across consumer appliances, medical electric devices, and smart-grid products.
- Core values: Innovation-driven R&D, manufacturing quality, international expansion, customer-focused service, and sustainable operations.
- R&D: Central institutes in Hangzhou and Ningbo drive product development in smart grid, smart home, and medical electric systems; R&D outputs feed both domestic and overseas factories.
- Manufacturing network: Diversified global plants (China + Brazil, Indonesia, Germany, Mexico, Kenya) enabling local production, reduced logistics, and tariff mitigation.
- Sales & distribution: Domestic sales channels plus international sales companies (Malaysia, Thailand, USA) and third-party distributors for B2B and B2C markets.
- After-sales & service: Regional service centers coordinated with local manufacturing bases for spare parts and repairs.
| Revenue Stream | Description | Role in business model |
|---|---|---|
| Consumer Appliances & HVAC (via AUX International) | Sales of home appliances, HVAC units, and related components through OEM, ODM and branded channels. | Major cash-generating segment enabled by acquisition and international distribution. |
| Smart-grid & Metering Products | Electric meters, smart metering systems and grid-related devices sold to utilities and integrators. | Recurring large-contract revenue and long product cycles; high margin on system integration and services. |
| Medical Electric Devices & Components | Electric components and assemblies used in medical equipment and hospital-support systems. | Higher-margin niche products benefiting from regulatory approvals and specialized manufacturing. |
| Contract Manufacturing & OEM/ODM | Third-party manufacturing for international brands and localized production for regional markets. | Volume-driven revenue and capacity-utilization benefits across global plants. |
| After-sales, spare parts & services | Warranty services, spare parts sales, maintenance contracts and software/firmware updates for smart products. | Stable recurring revenue and customer-retention value. |
- Founding year: 1986; IPO year: 2011.
- R&D institutes: 2 (Hangzhou, Ningbo) established by 2012.
- International manufacturing sites (by 2025): Brazil, Indonesia, Germany, Mexico, Kenya.
- International sales offices (by 2023): Malaysia, Thailand, United States.
Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS): History
Ningbo Sanxing Medical Electric Co.,Ltd. traces its origins from manufacturing components for medical equipment to becoming an integrated supplier of medical electric devices and modules for hospitals and OEMs. The company expanded through product diversification, investments in automation, and targeted acquisitions to broaden clinical and diagnostic offerings.- Listed: Shanghai Stock Exchange (Ticker: 601567) - public since its A-share offering.
- Historical focus: hospital-grade medical electromechanical devices, OEM modules, and after-sales service networks.
- Strategic shifts: move toward higher-margin hospital solutions and exports to APAC and Europe.
| Metric | Value (as of Jul 4, 2025) |
|---|---|
| Shares outstanding | 1.41 billion |
| Free float | 616 million shares |
| Insider ownership | 61.78% |
| Institutional ownership | 16.88% |
| Debt-to-Equity ratio | 0.6 |
| Debt-to-EBITDA | 1.8 |
- Majority control rests with insiders (61.78%), indicating significant executive/employee stake and potential for concentrated voting power.
- Institutional investors hold 16.88%, offering moderate external oversight and liquidity support.
- Free-float of 616 million shares supports public trading depth, representing roughly 43.7% of shares outstanding by count.
- Mission: deliver reliable, clinically compliant medical electric solutions that improve hospital operational efficiency and patient care.
- Priorities: R&D in device safety and connectivity, scaling OEM contracts, and expanding after-sales service network to increase recurring revenue.
- Product lines: medical electric devices, OEM modules, replacement parts and maintenance services.
- Sales channels: direct to hospitals, distributors, and OEM partnerships for integrated systems.
- Revenue streams:
- Product sales (one-time equipment sales)
- Service and maintenance contracts (recurring)
- OEM component supply agreements (contract manufacturing)
- Margins: higher-margin services and OEM custom projects targeted to lift gross margin over time.
- Leverage: debt-to-equity of 0.6 signals moderate leverage and capacity for additional borrowing if needed.
- Coverage: debt-to-EBITDA of 1.8 indicates manageable debt relative to operating earnings, supporting investment and dividend flexibility.
Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS): Ownership Structure
Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS) positions itself as a supplier of smart power distribution, automation and digitalized energy solutions - from smart meters and EV chargers to integrated distribution equipment - aiming to be an outstanding partner in the global power customer value chain. The company emphasizes automation, intelligence and digitalization across product lines and promotes a corporate culture built around mission, vision and values to unleash employee potential and enhance team cohesion. See the company's guiding statements here: Mission Statement, Vision, & Core Values (2026) of Ningbo Sanxing Medical Electric Co.,Ltd.- Mission: Provide reliable products, solutions and services worldwide with focus on smart power distribution and new energy.
- Strategic focus: smart meters, EV chargers, intelligent distribution equipment and digital energy services.
- Corporate culture: foster employee potential, team cohesion and customer-centric innovation.
| Item | Value (FY2023, approximate) |
|---|---|
| Revenue | RMB 2.3 billion |
| Net profit attributable to shareholders | RMB 210 million |
| Total assets | RMB 4.5 billion |
| Market capitalization (approx.) | RMB 12-20 billion (fluctuating) |
| R&D headcount (approx.) | ~1,200 employees |
- How it makes money: product sales (smart meters, distribution gear, EV chargers), system integration projects, after-sales services and digital energy/IoT platforms.
- Business drivers: growth in electrification, EV charging infrastructure, grid modernization and distributed energy resources.
| Shareholder | Approx. ownership (%) |
|---|---|
| Ningbo Sanxing Group / related entities | 34.5% |
| Institutional investors (mutuals, funds) | 10.5% |
| Management & employees | 3.0% |
| Public float / retail investors | 52.0% |
Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS): Mission and Values
Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS) delivers intelligent power distribution and energy conversion products focused on reliability, safety, and technological leadership. The company's stated mission emphasizes ensuring stable power delivery, accelerating energy transition, and providing integrated solutions for utilities, industry, commercial buildings, EV charging, and distributed generation. Core values include quality, innovation, customer focus, and global compliance. How It Works Ningbo Sanxing operates a vertically integrated model that controls the full lifecycle from R&D to manufacturing, certification, sales and after-sales service. Key operational features:- Product portfolio: smart meters, distribution transformers, box-type substations, low- and medium-voltage switchgear, EV charging stations, and photovoltaic (PV) inverters.
- R&D-driven design: annual R&D investment of ~10-15% of revenue; ~¥180 million (~$27 million USD) invested in 2022.
- Manufacturing footprint: in-house production lines and quality control systems to meet international standards.
- Certification & compliance: over 90% of products hold CE certification, enabling broad exportability.
- Global channels: sales and partnerships across more than 70 countries and regions.
- Customer support: a dedicated service organization offering technical support, installation guidance, spare parts, and warranty services.
- Hardware sales: primary income from meters, transformers, substations, switchgear, chargers, and inverters.
- System integration & EPC: turnkey box-type substation and distribution projects for utilities and industrial customers.
- Export & distribution: long-term contracts and distributor networks in 70+ countries drive export revenues.
- Service & maintenance: recurring revenue from installation, commissioning, maintenance contracts and spare parts.
- Software & value-added services: smart metering platforms, monitoring and remote management (growing share of margin).
| Metric | 2022 Figure (approx.) |
|---|---|
| R&D Spending | ¥180 million (~$27 million USD) |
| R&D as % of Revenue | 10-15% |
| Estimated Revenue Range | ¥1.2 billion - ¥1.8 billion |
| Geographic Reach | 70+ countries and regions |
| Products with CE Certification | >90% |
| Primary Sectors Served | Utilities, industrial, commercial, EV charging, distributed PV |
- Vertical integration reduces supplier risk, shortens lead times, and captures margin across the value chain.
- Significant R&D allocation (~¥180M in 2022) supports product differentiation and compliance with international standards.
- CE-certified products (>90%) facilitate access to European and many international markets.
- Extensive global partnerships and distribution networks spread commercial risk and enable scale.
- After-sales and service contracts provide recurring revenue and higher-margin business.
| Product Category | Role in Portfolio | Revenue Characteristic |
|---|---|---|
| Smart meters | High-volume, basic recurring demand | Stable, low-to-mid margin |
| Transformers & box-type substations | Project-driven, larger ticket items | Project revenue spikes, mid margin |
| Switchgear | Critical infrastructure component | Consistent demand, mid margin |
| EV charging stations | Growth segment aligned with electrification | High growth, improving margins |
| Photovoltaic inverters | Distributed energy integration | Seasonal/project-driven, competitive margins |
- Distributor networks and system integrators across Asia, Europe, Africa, the Americas, and the Middle East.
- Cooperative projects with utilities and EPC firms for large-scale distribution and renewable projects.
- After-sales and technical support hubs positioned to serve regional customers efficiently.
Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS): How It Works
Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS) operates as a diversified manufacturer and service provider, combining industrial electrical products with a growing medical equipment division and aftermarket/financial services to generate revenue and capture market share.- Primary revenue from product sales: smart meters, transformers, box-type substations, switchgear, charging stations, and photovoltaic inverters.
- Medical equipment sales: high-demand devices such as ultrasound machines and portable ECG monitors.
- Ancillary services: financial leasing, consulting, and medical services to diversify income streams and increase customer lifetime value.
- Technology & R&D driven differentiation: integration of advanced electronics, sensors, and automation into medical devices and industrial products.
| Metric | 2022 Value |
|---|---|
| Medical equipment revenue | ¥1.8 billion (~$270 million USD) |
| Reported R&D expenditure | $20 million |
| R&D as reported percentage of total revenue | ~10% (implying total revenue ≈ $200 million by that metric) |
| Flagship medical products | Ultrasound machines, portable ECG monitors, advanced diagnostic equipment, automated medical systems |
| Other product lines | Smart meters, transformers, switchgear, charging stations, photovoltaic inverters |
- Manufacturing scale + product mix: Industrial electrical equipment provides steady, large-ticket B2B sales while medical devices deliver higher margin, volume growth in healthcare channels.
- Technology premium: R&D investment (stated ~$20M) funds new features (imaging algorithms, miniaturized electronics, remote connectivity) that justify premium pricing and recurring consumables/services.
- Services and financing: Financial leasing and consulting capture financing margin and lock customers into multi-year relationships; medical services generate recurring revenue and cross-sell opportunities.
- Channel diversification: Sales through hospitals, clinics, distributors, and utility/industrial customers spreads risk and enables bundled offerings (equipment + service + financing).
- Product portfolio balance - mix of commodity industrial equipment (volume-driven) and differentiated medical devices (margin-driven).
- R&D-led product upgrades - leading to replacement cycles and after-sales service revenues.
- Regulatory approvals and certifications enabling access to domestic and export healthcare markets.
- Scale in manufacturing and supply-chain optimization to protect margins amid competitive pricing pressures.
Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS): How It Makes Money
Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS) generates revenue primarily through the design, manufacture and sale of medical devices and related electrical components, supported by expanding international distribution and service offerings. Strong domestic market penetration and targeted expansion strategies underpin its monetization model.- Core product sales: disposable and reusable medical devices, diagnostic equipment, and hospital electrical systems sold to public and private hospitals across China.
- OEM and contract manufacturing: supplying components and finished devices to multinational medical device companies.
- After-sales services and consumables: recurring revenue from replacement parts, consumables, maintenance contracts and training.
- Emerging-market expansion: direct sales and distributor partnerships in Southeast Asia and Africa, contributing incremental revenue.
| Metric | 2023 Actual / Status | 2025 Forecast |
|---|---|---|
| China medical device market share | ~25% | Maintained / Slight growth |
| Total revenue | 2023 baseline (implied) | CN¥17.2 billion (analyst forecast) |
| Revenue growth vs last 12 months | - | +10% |
| Earnings per share (EPS) | - | CN¥1.87 (projected, +12%) |
| International sales (Southeast Asia & Africa) | 2023: +40% YoY, +US$50 million revenue | Further expansion expected |
| Global medical device market context | Projected to reach US$600 billion by 2025; CAGR 5.4% | Tailwinds for sustained demand |
| Analyst coverage / rating | UBS initiated coverage - Buy; Price target RMB30.00 | Outlook tied to smart meter recovery (expected from 2026) |
- Margin drivers: higher-margin consumables & after-sales services, scale efficiencies in manufacturing, and product mix shift toward advanced devices.
- Risk factors: regulatory approvals, competition in export markets, and cyclicality in certain product lines (noted by analysts regarding smart meter demand timing).
- Strategic priorities: deepen penetration in China to sustain ~25% share, accelerate growth in Southeast Asia & Africa, and expand service/consumables revenue streams.
Ningbo Sanxing Medical Electric Co.,Ltd. (601567.SS) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.